Skip to content
Artwork for Retina Synthesis

Retina Synthesis

Retina Synthesis

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Play
  • 23 episodes
  • weekly
  • Avg 18 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • #188
    August 19 · 30 min

    The ASRS ReST Commitee

    In this episode, we review the work of the Research in Safety and Therapeutics (ReST)Committee of the American Society of Retinal Specialists (ASRS) with Dr. Andre Witkin, Chair of the ReST Committee, and Professor of Ophthalmology at Tufts University School of Medicine, New England Eye Center, and Ophthalmic Consultants of Boston.

  • #186
    August 4 · 19 min

    Hand Held Office Based ERG for Evaluating Diabetic Retinopathy

    In this episode, we discuss the use of handheld ERG in the evaluating eye with diabetic retinopathy. ERG is a powerful predictive tool in assessing diabetic retinopathy. Our guest is Dr. Raj Maturi of the Midwest Eye Institute and Adjunct Associate Professor of Ophthalmology, at the Indiana University School of Medicine.

  • #185
    July 30 · 11 min

    4 Year Outcomes of Faricimab Therapy of Neovascular AMD

    In this episode, we discuss the long term results of faricimab therapy of neovascular AMD with Dr. Carl Danzig of Fort Lauderdale, Florida and Affiliate Assistant Professor at the Charles Schmidt School of Medicine at Florida Atlantic University.

  • #184
    July 21 · 11 min

    5 Year Results of Pegacetacoplan Treatment of Geographic Atrophy

    In this episode, we discuss 5 year results of the GALE study which demonstrated that earlier treatment with pegcetacoplan of geographic atrophy preserves more retinal tissue with Dr. Dilsher Dhoot, California Retina Consultants, Adjunct Clinical Assistant Professor Ophthalmology, Roski Eye Institute, Keck School of Medicine of USC.

  • #183
    July 15 · 16 min

    Polychoroidal Vasculopathy (PCV)

    In this episode, we discuss the importance of early recognition of PCV, diagnostic techniques, and therapeutic approaches with Professor Jay Chhablani of the University of Pittsburgh.

  • #182
    July 7 · 19 min

    AREDS Vitamins and Geographic Atrophy

    In this episode, we review the evidence regarding the effectiveness of AREDS vitamin supplementation in affecting the growth of geographic atrophy in age related macular degeneration.

  • #181
    June 16 · 20 min

    Intravitreal Gene Therapy for Neovascular AMD with 4D-150

    In this episode, we discuss the promising results of intravitreal gene therapy for neovascular AMD with 4D-150 with Dr. Arshad Khanani of Sierra Eye Associates and Clinical Professor of Ophthalmology at the University of Nevada Medical School, Reno.

  • #180
    June 8 · 22 min

    Home OCT in Management of Neovascular AMD

    In this episode, we discuss the latest developments in the use of artificial intelligence in home OCT for management of neovascular AMD with Professor Anat Loewenstein of Tel Aviv Medical Center and President, Israeli Ophthalmology Society.

  • #179
    June 4 · 13 min

    Faricimab in the Treatment of DME: Long Term 'Results

    We discuss long term results of faricimab treatment of DME, with the first author of the Ophthalmology article on the results of Rhone-X trial, Dr. Veeral Sheth, Director of Clinical Research at University Retina in Chicago.

  • #178
    May 28 · 17 min

    Xelafaslatide for the Treatment of Geographic Atrophy

    In our latest episode we discuss the results of a novel approach to the treatment of geographic atrophy using Xelafaslatide a Fas inhibitor with Dr. David Zacks, Professor of Ophthalmology at the Kellogg Eye Center at the University of Michigan.

  • #177
    May 19 · 12 min

    Inhibition of IL-6 in the Treatment of Retinal Disease

    In our latest episode, we discuss the use of inhibitors of IL-6 in the treatment of retinal disease with Dr. Steven M. Yeh, Stanley M. Truhlsen, Jr. , Chair of Ophthalmology a the University of Nebraska.

  • #176
    May 12 · 14 min

    Aflibercept 8mg for Retinal Vein Occlusion

    In this episode, we discuss the use of aflibercept 8mg for the management of retinal vein occlusion and the results of the QUASAR study with Dr. Sunir Garg, Co Director of Retina Research at the Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.

  • #172
    April 7 · 20 min

    Kamuvudine 8 in the Treatment of Geographic Atrophy

    In our latest episode with the discuss the promising results of a Phase I clinical trial looking at kamuvudine 8 an inflammasome inhibitor in the treatment of geographic atrophy with Dr. Jayakrishna Ambati, Guerry Professor of Ophthalmology at the University of Virginia School of Medicine.

  • #171
    March 31 · 14 min

    Treatment of Proliferative Diabetic Retinopathy After Protocol S

    In this episode, we discuss real world treatment of proliferative diabetic retinopathy using data from the Vestrum data base; with Dr. Adrienne Scott, Fred M. Leader Family Retina Professor of the Wilmer Eye Institute and Johns Hopkins University School of Medicine.

  • #170
    March 24 · 16 min

    Encapsulated Cell Therapy for MacTel2

    In this episode, we discuss the pathbreaking use of an encapsulated cell therapy that produces CNTF for the successful treatment of MacTel with Roger Goldberg, MD, from Walnut Creek, CA.

Showing 1–20 of 23 episodes